Detection and classification of neurodegenerative diseases: a spatially informed bayesian deep learning approach

Dissertation submitted in partial fulfilment of the requirements for the Degree of Master of Science in Geospatial TechnologiesNeurodegenerative diseases comprise a group of chronic and irreversible conditions characterized by the progressive degeneration of the structure and function of the central nervous system. The detection and classification of patients according to the underlying disease are crucial for developing oriented treatments and enriching prognosis. In this context, Magnetic resonance imaging (MRI) data can provide meaningful insights into neurodegeneration by detecting the physiological manifestations in the brain caused by the disease processes. One field of extensive clinical use of MRI is the accurate and automated classification of neurodegenerative disorders. Most studies distinguish patients from healthy subjects or stages within the same disease. Such distinction does not mirror clinical practice, as a patient may not show all symptoms, especially if the disease is in an early stage, or show, due to comorbidities, other symptoms as well. Likewise, automated classifiers are partly suited for medical diagnosis since they cannot produce probabilistic predictions nor account for uncertainty. Also, existent studies ignore the spatial heterogeneity of the brain alterations caused by neurodegenerative processes. The spatial configuration of the neuronal loss is a characteristic hallmark for each disorder. To fill these gaps, this thesis aims to develop a classification technique that incorporates uncertainty and spatial information for distinguishing four neurodegenerative diseases, Alzheimer’s disease, Mild cognitive impairment, Parkinson’s disease and Multiple Sclerosis, and healthy subjects. This technique will produce automated, contingent, and accurate predictions to support clinical diagnosis. To quantify prediction uncertainty and improve classification accuracy, this study introduces a Bayesian neural network with a spatially informed input. A convolutional neural network (CNN) is developed to identify a neurodegenerative condition based on T1weighted MRI scans from patients and healthy controls. Bayesian inference is incorporated into the CNN to measure uncertainty and produce probabilistic predictions. Also, a spatially informed MRI scan is added to the CNN to improve feature detection and classification accuracy. The Spatially informed Bayesian Neural Network (SBNN) proposed in this work demonstrates that classification accuracy can be increased up to 25% by including the spatially informed MRI scan. Furthermore, the SBNN provides robust probabilistic diagnosis that resembles clinical decision-making and accounts for atypical, numerous, and early presentations of neurodegenerative disorders

A 3D Fully Convolutional Neural Network With Top-Down Attention-Guided Refinement for Accurate and Robust Automatic Segmentation of Amygdala and Its Subnuclei

Recent advances in deep learning have improved the segmentation accuracy of subcortical brain structures, which would be useful in neuroimaging studies of many neurological disorders. However, most existing deep learning based approaches in neuroimaging do not investigate the specific difficulties that exist in segmenting extremely small but important brain regions such as the subnuclei of the amygdala. To tackle this challenging task, we developed a dual-branch dilated residual 3D fully convolutional network with parallel convolutions to extract more global context and alleviate the class imbalance issue by maintaining a small receptive field that is just the size of the regions of interest (ROIs). We also conduct multi-scale feature fusion in both parallel and series to compensate the potential information loss during convolutions, which has been shown to be important for small objects. The serial feature fusion enabled by residual connections is further enhanced by a proposed top-down attention-guided refinement unit, where the high-resolution low-level spatial details are selectively integrated to complement the high-level but coarse semantic information, enriching the final feature representations. As a result, the segmentations resulting from our method are more accurate both volumetrically and morphologically, compared with other deep learning based approaches. To the best of our knowledge, this work is the first deep learning-based approach that targets the subregions of the amygdala. We also demonstrated the feasibility of using a cycle-consistent generative adversarial network (CycleGAN) to harmonize multi-site MRI data, and show that our method generalizes well to challenging traumatic brain injury (TBI) datasets collected from multiple centers. This appears to be a promising strategy for image segmentation for multiple site studies and increased morphological variability from significant brain pathology